# FDA Inspection 1122782 - Crouse Hospital Human Research Review Committee - March 17, 2020

Source: https://www.keypedia.com/records/fda_inspections/crouse-hospital-human-research-review-committee/2d2d1a9c-3676-41ca-9f27-0faaddbbcfb1
Source feed: FDA_Inspections

> FDA Inspection 1122782 for Crouse Hospital Human Research Review Committee on March 17, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1122782
- Company Name: Crouse Hospital Human Research Review Committee
- Inspection Date: 2020-03-17
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1122782 - 2020-03-17](https://www.keypedia.com/records/fda_inspections/crouse-hospital-human-research-review-committee/2315545b-1843-4194-b823-31064db681f6)
- [FDA Inspection 1122782 - 2020-03-17](https://www.keypedia.com/records/fda_inspections/crouse-hospital-human-research-review-committee/96414b40-1944-4e18-9d04-992928366478)
- [FDA Inspection 883691 - 2014-05-30](https://www.keypedia.com/records/fda_inspections/crouse-hospital-human-research-review-committee/17b45d0f-3e19-4c5b-a647-2edc9be6b584)

Company: https://www.keypedia.com/companies/crouse-hospital-human-research-review-committee/212eab1d-a645-431c-b7e0-8960886438ea

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d